Steward Partners Investment Advisory’s Vaxart VXRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-35,000
Closed -$23.4K 3858
2024
Q2
$23.4K Hold
35,000
﹤0.01% 2456
2024
Q1
$45.5K Buy
35,000
+18,000
+106% +$18.9K ﹤0.01% 2162
2023
Q4
$9.74K Hold
17,000
﹤0.01% 2724
2023
Q3
$12.8K Hold
17,000
﹤0.01% 2491
2023
Q2
$12.4K Buy
17,000
+16,400
+2,733% +$15.2K ﹤0.01% 2495
2023
Q1
$454 Sell
600
-1,000
-63% -$929 ﹤0.01% 3182
2022
Q4
$1.54K Sell
1,600
-400
-20% -$565 ﹤0.01% 3069
2022
Q3
$4K Hold
2,000
﹤0.01% 2885
2022
Q2
$7K Hold
2,000
﹤0.01% 2657
2022
Q1
$10K Sell
2,000
-1,413
-41% -$7.16K ﹤0.01% 2678
2021
Q4
$21K Buy
3,413
+353
+12% +$2.41K ﹤0.01% 2308
2021
Q3
$24K Buy
3,060
+1,000
+49% +$8.23K ﹤0.01% 2253
2021
Q2
$15K Sell
2,060
-3,110
-60% -$21.7K ﹤0.01% 5513
2021
Q1
$31.3K Buy
+5,170
New +$39.8K ﹤0.01% 2238

Other funds holding VXRT

Steward Partners Investment Advisory's VXRT Position: Q3 2024 in Review

Steward Partners Investment Advisory sold out of Vaxart (VXRT) in Q3 2024, closing a stake of 35,000 shares — an estimated $23.4K sold.

Steward Partners Investment Advisory first reported a position in VXRT in Q1 2021 and held it in 14 quarters. The position peaked at $45.5K in Q1 2024. 100 funds tracked by Wall St. Rank hold VXRT as of Q3 2024.

  • Steward Partners Investment Advisory reported no remaining Vaxart position as of Q3 2024 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 35,000 Vaxart shares in Q3 2024, an estimated $23.4K.
  • Steward Partners Investment Advisory first reported a position in Vaxart in Q1 2021 and held it in 14 quarters.
  • Steward Partners Investment Advisory's Vaxart position peaked at $45.5K in Q1 2024.
  • 100 funds tracked by Wall St. Rank held Vaxart as of Q3 2024.

Based on Steward Partners Investment Advisory's 13F filing for Q3 2024, filed 14 Nov 2024.